Minnesota FOIA #P008900102

Targeting N-Myc with Selective Aurora Kinase A Degraders for Neuroblastoma TherapyBudget period 7/15/22-7/14/24

This purchase order, issued by TWIN_CITIES, awards a research contract to UT HEALTH SAN ANTONIO for the project titled 'Targeting N-Myc with Selective Aurora Kinase A Degraders for Neuroblastoma Therapy,' with a total obligated amount of $202,724. The contract covers a project period from July 15, 2022, to July 14, 2024. The vendor, UT HEALTH SAN ANTONIO, is located in San Antonio, Texas, USA, with NAICS code 541714 (Research and Development in Biotechnology). The procurement was initiated on May 5, 2023, and involves a single line item for the specified research project. The award is managed by the TWIN_CITIES entity, which appears to be a regional or organizational designation, and the recipient is a university medical research institution. No specific contacts or additional locations are provided. Likely competitors for similar awards could include biotech and research organizations such as Genentech, Novartis, or Pfizer.

Description

Targeting N-Myc with Selective Aurora Kinase A Degraders for Neuroblastoma TherapyBudget period 7/15/22-7/14/24